Comparison of rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects

被引:16
|
作者
Theunissen, Peter T. [1 ,2 ,3 ]
Beken, Sonja [4 ]
Beyer, Bruce K. [5 ]
Breslin, William J. [6 ]
Cappon, Gregg D. [7 ]
Chen, Connie L. [8 ]
Chmielewski, Gary [9 ]
De Schaepdrijver, Luc [10 ]
Enright, Brian [11 ]
Foreman, Jennifer E. [12 ]
Harrouk, Wafa [13 ]
Hew, Kok-Wah [14 ]
Hoberman, Alan M. [15 ]
Hui, Julia Y. [16 ]
Knudsen, Thomas B. [17 ]
Laffan, Susan B. [18 ]
Makris, Susan L. [19 ]
Martin, Matt [17 ]
McNerney, Mary Ellen [20 ]
Siezen, Christine L. [2 ]
Stanislaus, Dinesh J. [18 ]
Stewart, Jane [21 ]
Thompson, Kary E. [20 ]
Tornesi, Belen [11 ]
Van der Laan, Jan Willem [1 ,2 ]
Weinbauer, Gerhard F. [22 ]
Wood, Sandra [23 ]
Piersma, Aldert H. [1 ,24 ]
机构
[1] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, Bilthoven, Netherlands
[2] Med Evaluat Board, Graadt van Roggenweg 500, NL-3531 AH Utrecht, Netherlands
[3] Univ Appl Sci Utrecht HU, Innovat Testing Life Sci & Chem, Utrecht, Netherlands
[4] Fed Agcy Med & Hlth Prod, Brussels, Belgium
[5] Sanofi US Inc, Bridgewater, NJ USA
[6] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN USA
[7] Pfizer Worldwide Res & Dev, Groton, CT USA
[8] ILSI Hlth & Environm Sci Inst, Washington, DC USA
[9] Covance Labs Inc, Greenfield, IN USA
[10] Janssen R&D, Preclin Dev & Safety Beerse, Beerse, Belgium
[11] AbbVie Inc, N Chicago, IL USA
[12] ExxonMobil Biomed Sci Inc, Annandale, NJ USA
[13] US FDA, Silver Spring, MD USA
[14] Takeda Pharmaceut Co, Deerfield, IL USA
[15] Charles River Labs, Preclin Serv, Horsham, PA USA
[16] Celgene Corp, Summit, NJ USA
[17] US EPA, Natl Ctr Computat Toxicol, Res Triangle Pk, NC 27711 USA
[18] GlaxoSmithKline, Safety Assessment, King Of Prussia, PA USA
[19] US EPA, Natl Ctr Environm Assessment, Washington, DC 20460 USA
[20] Bristol Myers Squibb, Drug Safety Evaluat, New Brunswick, NJ USA
[21] AstraZeneca, Drug Safety & Metab, Macclesfield, Cheshire, England
[22] Covance Preclin Serv GmbH, Munster, Germany
[23] Merck Res Labs, Upper Gwynedd, PA USA
[24] Univ Utrecht, Inst Risk Assessment Sci, Fac Vet Sci, Utrecht, Netherlands
关键词
Pharmaceutical testing; embryo-fetal developmental toxicity; cross-species evaluation; non-clinical; IN-VITRO; THALIDOMIDE; ABNORMALITIES; ANIMALS;
D O I
10.1080/10408444.2016.1224807
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Regulatory non-clinical safety testing of human pharmaceuticals typically requires embryo-fetal developmental toxicity (EFDT) testing in two species (one rodent and one non-rodent). The question has been raised whether under some conditions EFDT testing could be limited to one species, or whether the testing in a second species could be decided on a case-by-case basis. As part of a consortium initiative, we built and queried a database of 379 compounds with EFDT studies (in both rat and rabbit animal models) conducted for marketed and non-marketed pharmaceuticals for their potential for adverse developmental and maternal outcomes, including EFDT incidence and the nature and severity of adverse findings. Manifestation of EFDT in either one or both species was demonstrated for 282 compounds (74%). EFDT was detected in only one species (rat or rabbit) in almost a third (31%, 118 compounds), with 58% (68 compounds) of rat studies and 42% (50 compounds) of rabbit studies identifying an EFDT signal. For 24 compounds (6%), fetal malformations were observed in one species (rat or rabbit) in the absence of any EFDT in the second species. In general, growth retardation, fetal variations, and malformations were more prominent in the rat, whereas embryo-fetal death was observed more often in the rabbit. Discordance across species may be attributed to factors such as maternal toxicity, study design differences, pharmacokinetic differences, and pharmacologic relevance of species. The current analysis suggests that in general both species are equally sensitive on the basis of an overall EFDT LOAEL comparison, but selective EFDT toxicity in one species is not uncommon. Also, there appear to be species differences in the prevalence of various EFDT manifestations (i.e. embryo-fetal death, growth retardation, and dysmorphogenesis) between rat and rabbit, suggesting that the use of both species has a higher probability of detecting developmental toxicants than either one alone.
引用
收藏
页码:900 / 910
页数:11
相关论文
共 38 条
  • [21] An Analysis of Rat and Rabbit Developmental Toxicity Studies for Pharmaceuticals: The Scientific Background
    Piersma, A. H.
    Theunissen, P. T.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (05) : 364 - 364
  • [22] Evaluation of levamlodipine benzenesulfonate compound I for embryo-fetal developmental toxicity in SD rats and genotoxicity
    Tian, Yijun
    Shi, Wenjing
    Liu, Fengjiang
    Li, Huan
    Zhang, Tianbao
    Zhu, Yuping
    [J]. REPRODUCTIVE TOXICOLOGY, 2024, 129
  • [23] Vehicle Toxicity: The Effects of Commonly Used Vehicles in a Rabbit Embryo-Fetal Development Study
    Donahue, D. A.
    Schroeder, C. A.
    Jordan, H. L.
    Quigley, K.
    Sterrett, T. J.
    Staudner, H. A.
    John, C. K.
    Akinola, A. Y.
    Groeller, A. K.
    Gust, T.
    Reichter, T.
    Qualls, C. D.
    Weinbauer, G. F.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2018, 37 (01) : 65 - 65
  • [24] The predictivity of preliminary embryo-fetal developmental toxicity studies: An ICH-M3 survey in Japan
    Okahashi, Noriko
    Ikeda, Takashi
    Kai, Shuichi
    Komatsu, Shinichi
    Matsui, Hajime
    Yamashita, Yasuhiro
    Yamamoto, Keiji
    Sagami, Fumio
    [J]. TOXICOLOGY LETTERS, 2008, 180 : S155 - S155
  • [25] Embryo-Fetal Developmental Toxicity of Compounded Diphenhydramine Hydrochloride and Caffeine Formulation Tested on Pregnant SD Rats
    Yan, Lang
    Shi, Wenjing
    Ren, Lijun
    Wang, Ruina
    Li, Jinfeng
    Gao, Fangyuan
    Zhang, Jiqianzhu
    Tian, Yijun
    Chen, Jikuai
    Zhu, Jiangbo
    Zhang, Xiaofang
    [J]. PHARMACEUTICAL CHEMISTRY JOURNAL, 2023, 57 (02) : 274 - 283
  • [26] Embryo-Fetal Developmental Toxicity of Compounded Diphenhydramine Hydrochloride and Caffeine Formulation Tested on Pregnant SD Rats
    Lang Yan
    Wenjing Shi
    Lijun Ren
    Ruina Wang
    Jinfeng Li
    Fangyuan Gao
    Jiqianzhu Zhang
    Yijun Tian
    Jikuai Chen
    Jiangbo Zhu
    Xiaofang Zhang
    [J]. Pharmaceutical Chemistry Journal, 2023, 57 : 274 - 283
  • [27] Rat embryo culture using rabbit serum as a medium for developmental toxicity studies
    Nakajima, M
    Sasaki, M
    Kobayashi, Y
    Ohno, Y
    Usami, M
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 1997, 17 (03) : 185 - 188
  • [28] Maternal Exposure to Multi-Wall Carbon Nanotubes Does Not Induce Embryo-Fetal Developmental Toxicity in Rats
    Lim, Jeong-Hyeon
    Kim, Sung-Hwan
    Shin, In-Sik
    Park, Na-Hyeong
    Moon, Changjong
    Kang, Seong-Soo
    Kim, Sung-Ho
    Park, Seung-Chun
    Kim, Jong-Choon
    [J]. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY, 2011, 92 (01) : 69 - 76
  • [29] A Comprehensive Data Survey of the Relative Value of Rat versus Rabbit Developmental Toxicity Data in the Risk Assessment for Pharmaceuticals: Presentation of Results
    Theunissen, P. T.
    Piersma, A. H.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (05) : 365 - 365
  • [30] Induction of cytochrome P450 3A1 expression by diallyl disulfide: Protective effects against cyclophosphamide-induced embryo-fetal developmental toxicity
    Kim, Sung-Hwan
    Lee, In-Chul
    Baek, Hyung-Seon
    Moon, Changjong
    Kim, Sung-Ho
    Yoo, Jin Cheol
    Shin, In-Sik
    Kim, Jong-Choon
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2014, 69 : 312 - 319